http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9211435

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Comparative Study|Journal Article|Randomized Controlled Trial|Research Support, U.S. Gov't, P.H.S.
endingPage 1847
issn 0028-3878
1526-632X
issueIdentifier 10
pageRange 1845-1847
publicationName Neurology
startingPage 1845
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0a5a04b38cac9d81d372a4fbb5ee5855
bibliographicCitation Gordon PH, Moore DH, Gelinas DF, Qualls C, Meister ME, Werner J, Mendoza M, Mass J, Kushner G, Miller RG. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology. 2004 May 25;62(10):1845–7. doi: 10.1212/01.wnl.0000125321.92112.7e. PMID: 15159491.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ffffb50383474eacecb9872c998184a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04e3d2736ada056988996248eb10bb98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3c93e5a72fa456e77f29ee8c8adf485
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c0c6c124a701a16c9daa2069265771d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_735a06d5a318db2c7a0a1b9ff5ca209c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bacbefe3dc6ea70956764db77f927dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cc05bae118886c8e8003f031dbb7ccc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_142571c05d2c8295fb5a763bdb9e58b7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c313d3b2c3c95f606e25bcd761a0af59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2b830960146bdd7bf333dc0e46f462b
date 2004-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/15159491
https://doi.org/10.1212/01.wnl.0000125321.92112.7e
isPartOf https://portal.issn.org/resource/ISSN/1526-632X
https://portal.issn.org/resource/ISSN/0028-3878
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6069
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
discusses http://id.nlm.nih.gov/mesh/M0028008
http://id.nlm.nih.gov/mesh/M0013912
http://id.nlm.nih.gov/mesh/M0029347
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000690Q000188
http://id.nlm.nih.gov/mesh/D018696Q000627
http://id.nlm.nih.gov/mesh/D008911Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D019782Q000627
http://id.nlm.nih.gov/mesh/D056486
http://id.nlm.nih.gov/mesh/D008911Q000009
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D007674Q000139
http://id.nlm.nih.gov/mesh/D018696Q000009
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005767Q000139
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019782Q000008
http://id.nlm.nih.gov/mesh/D012132Q000187
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D018696Q000494
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008911Q000494
http://id.nlm.nih.gov/mesh/D008911Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D018737
http://id.nlm.nih.gov/mesh/D018696Q000008
http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31295

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127788218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127895450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129979483

Total number of triples: 67.